Академический Документы
Профессиональный Документы
Культура Документы
Statistics
>9.7 million cases are detected each year 6.7 million people will die from cancer Every day, around 1700 Americans die of the disease 20.4 million people living with cancer in the world today 1 in 3 people will be diagnosed with cancer in the UK and 1 in 4 will die from their disease
Liver
Prostate Cervix uteri Oesophagus Bladder Non-Hodgkin Lymphoma Leukaemia Oral cavity Pancreas Kidney
Ovary
99
167 93 144 109 170 81 116 112 119 57
Incidence Mortality
1000 0
800
600
400
200 0 (Thousands)
200
400
600
800 100
WHO Statistics
population
What is neoplasm?
Oncogenes-tumor causers
Tumour suppressor genes Suicide genes apoptosis DNA repair genes
Growth
Tumour
Pressure
on nerves Blocking organs Stopping normal function Altering nerve signals Obstructs
Angiogenesis-creation
of new
microcirculation
Types of Cancer
Carcinomas Sarcomas Lymphomas Leukaemias Adenomas
What are the differences in the features of normal and cancer cells?
Cancerous growth
Metastatic cancer
Methods of Metastasis-spread
By vascular system By lymph system By direct invasion
Good link
www.cancerresearchuk.org/cancerhelp/about-cancer.what-iscancer/grow/how-a-cancer-spreads
Immunity
Viruss
Hepatitis B
Human T-cell Leukaemia virus
Bacterial
Ano-genital
Nasopharyngeal Hodgkin disease Bladder Leukaemia Total
65,000
63,000 33,000 10,000 3,000 1,801,000
HPV
EBV EBV, HIV Schistosoma HTLV1
0.6
0.6 0.3 0.1 0.03 17.9
Chemical
Alcohol Asbestos Wood dust Rubber, plastics, dyes Tar / bitumen Aflatoxin Alkylating agents
Tobacco
Smoking
Single biggest cause of cancer 25-40% smokers die in middle age 9 in 10 lung cancers Know to cause cancer in 1950
Industrial pollution
Physical causes
Ultraviolet radiation
treatment
Obesity
Lifestyle:
- Highly caloric diet, rich in fat, refined carbohydrates and animal protein - Low physical activity
Consequences:
- Cancer - Diabetes - Cardiovascular disease - Hypertension
Lifestyle
Age
Occupation Ethnicity
Deprivation
Survival variations
CONCORD Study (1.9 million survivors) demonstrated a clear relationship to income not only between countries but also between the ethnic groups in those countries
Clinical History
Normal diagnostic procedures
Scans,
Pathological staging
Staging
Size
Invasion Lymph nodes Metastasises
TNM Staging
T (a,is,(0),1-4): size or direct extent of the primary tumor N (0-3): degree of spread to regional lymph nodes
N0: tumor cells absent from regional lymph nodes N1: tumor cells spread to closest or small number of regional lymph nodes N2: tumor cells spread to an extent between N1 and N3. N3: tumor cells spread to most distant or numerous regional lymph nodes M0: no distant metastasis M1: metastasis to distant organs (beyond regional lymph nodes)
Other parameters G (1-4): the grade of the cancer cells (i.e. they are "low grade" if they appear similar to normal cells, and "high grade" if they appear poorly differentiated) R (0/1/2): the completeness of the operation (surgeryboundaries free of cancer cells or not) L (0/1): invasion into lymphatics V (0/1): invasion into vein C (1-4): a modifier of the certainty (quality) of the last mentioned parameter
Examples
Small, low grade cancer, no metastasis, no spread to regional lymph nodes, cancer completely removed, resection material seen by pathologist - pT1 pN0 M0 R0 G1; this would be considered Stage I. Large, high grade cancer, with spread to regional lymph nodes and other organs, not completely removed, seen by pathologist - pT4 pN2 M1 R1 G3; this would be considered Stage IV. Most Stage I tumors are curable; most Stage IV tumors are not.
There are two different systems for staging chronic lymphocytic leukemia. The Rai classification is used more often in the United States, whereas the Binet system is used more widely in Europe
For adults, ALL is classified as untreated, in remission, or recurrent. For childhood ALL, risk groups are used instead of stages to describe cases of the disease. Risk groups for childhood ALL include: Standard (low) risk High risk Recurrent.
Other staging
Modified Duke A The tumor penetrates into the mucosa of the bowel wall but no further. Modified Duke B B1: tumor penetrates into, but not through the muscularis propria (the muscular layer) of the bowel wall. B2: tumor penetrates into and through the muscularis propria of the bowel wall. Modified Duke C C1: tumor penetrates into, but not through the muscularis propria of the bowel wall; there is pathologic evidence of colon cancer in the lymph nodes. C2: tumor penetrates into and through the muscularis propria of the bowel wall; there is pathologic evidence of colon cancer in the lymph nodes. Modified Duke D The tumor, which has spread beyond the confines of the lymph nodes (to organs such as the liver, lung or bone).
Summary